Heteroarylether 1,3-diarylureas in the thieno[3,2-d]pyrimidine series as VEGFR2 tyrosine Kinase inhibitors: synthesis, docking studies, enzymatic and cellular assays
A number of thienopyrimidines derivatives have shown potent YEGFR2 (Vascular Endothelium Growth Factor Receptor2) inhibition activity [ 1]. YEGF is a surrogate marker of angiogenesis that activates VEGFR2 in endothelial cells. VEGF induces proliferation, migration and anastomosis of these cells. Her...
Main Author: | |
---|---|
Other Authors: | , , , , , , , |
Format: | conferenceObject |
Language: | eng |
Published: |
2012
|
Online Access: | http://hdl.handle.net/10198/7357 |
Country: | Portugal |
Oai: | oai:bibliotecadigital.ipb.pt:10198/7357 |